Open Label Study in Adolescents and Children With Myotonic Disorders
NCT04624750
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Myotonic Dystrophy
Interventions
DRUG:
Mexiletine
Sponsor
Lupin Ltd.